| Name | sRANKL-IN-1 |
|---|
| Description | sRANKL-IN-1 (compound S3) is a sRANKL (soluble RANKL) inhibitor. sRANKL-IN-1 shows a potent osteoclast inhibition effect with an IC50 value of 0.096 μM and a KD value of 34.80 μM. sRANKL-IN-1 can be used for the research of osteoporosis[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.096 μM (osteoclast)[1] |
| In Vitro | sRANKL-IN-1 (0-50 μM) shows potent inhibition to osteoclast[1]. Cell Viability Assay[1] Cell Line: Bone marrow cell line Concentration: 0-50 μM Incubation Time: Until osteoclasts formed Result: Inhibited osteoclasts formation with an IC50 value of 0.096 μM and a KD value of 34.80 μM. |
| References |
| Molecular Formula | C18H18N4O6S |
|---|---|
| Molecular Weight | 418.42 |